Description
MyDay® is a one-day replacement silicone hydrogel contact lens for myopic and hyperopic patients.
Features & Benefits
- Aquaform® Technology for incredible all-day comfort2
- Premium optics that help deliver clear, crisp and sharp vision2
- Vision correction for 99.9% of spherical prescriptions3
- Four times the oxygen transmissibility of equivalent hydrogel one-day replacement contact lenses for clear, white eyes†‡2
- UV blocking to help protect the eye from the transmission of harmful UV rays#
- MyDay® sphere is plastic neutral. CooperVision offsets plastic waste for every box of MyDay® sphere contact lenses sold and distributed.♢2
| Aquaform® TechnologyAquaform® Technology allows water to be held throughout each MyDay® lens material, from its core to its surface, helping to keep it moist all day long. This provides natural wettability, without coatings or surface treatments to support an incredibly comfortable lens-wearing experience.2 |
| Aberration Neutralising System™Aspheric front surface design unique by lens power. It is designed to help counteract the eye's average spherical aberration, leading to clear vision.2 |
Product Details
-6.00 to -0.25DS (0.25D steps)
+0.25 to +5.00DS (0.25D steps)
+5.50 to +8.00DS (0.50D steps)
Packaging images for illustration purposes only.
* Vs. DAILIES TOTAL1®, PRECISION1®, ACUVUE® OASYS MAX 1-Day, ULTRA® One-Day.
† High oxygen transmissibility promotes clear, white eyes.
‡ Compared to 1 DAY ACUVUE® MOIST and DAILIES® AquaComfort Plus®.
# Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
♢ Plastic used in participating CooperVision soft contact lens products is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink). The determination does not include plastic used during the manufacturing process for both these products and their packaging.
References:
1. CVI data on file 2015, 2021, 2023, and 2023. MyDay® clinical studies compared to DAILIES TOTAL1® n=22 (dispense -0.09 vs -0.10 p=0.624), PRECISION1® n=35 (dispense -0.14 vs -0.14 p=0.90, 1 week -0.14 vs -0.15 p=0.14), ACUVUE® OASYS MAX 1-Day n=68 (dispense -0.10 vs -0.11 p=0.22, 1 week -0.10 vs -0.10 p=0.25), and ULTRA® One-Day n=64 (dispense -0.04 vs -0.04 p=0.79, 1 week -0.04 vs -0.04 p=0.54).
2. CVI data on file, 2024.
3. CooperVision data on file 2020. Rx coverage database n=120,406 eyes for Rx with <0.75DC; 14 to 70 years.
For the device safety, warnings, precaution, and local regulatory information, please refer to the Instruction for use leaflet.
SA12443 / APP132148
